Market Review: Stocks Resume Gains on Improving Investor and Consumer Sentiment
U.S. stocks resumed gains this week, driven by Nvidia's strong earnings, easing concerns in the bond market and over trade uncertainty, and a rebound in consumer confidence.
The S&P 500 Index closed May 30 at 5,911, up by 1.88 percent for the week. The Dow Jones Industrial Average gained 1.6 percent to finish at 42,270. The Nasdaq rose by 2.01 percent to 19,113, while the Russell 2000 posted smaller gains.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Nvidia and Dell to Build DOE-Backed AI Supercomputer 'Doudna' for 2026 Launch
Nvidia (NVDA, Financials) and Dell (DELL, Financials) on Thursday announced a collaboration with the U.S. Department of Energy to develop the Doudna supercomputer, which will be deployed at Lawrence Berkeley National Laboratory in 2026. The DOE said the system is named after Nobel laureate Jennifer Doudna and will be powered by Dell infrastructure and Nvidia's Vera Rubin AI platform. Warning! GuruFocus has detected 4 Warning Signs with NVDA. Doudna's performance output is expected to exceed that of Berkeley Lab's current Perlmutter system by a factor of three to five, while requiring only double or triple the power. According to the Department of Energy, the system will support high-performance computing workloads ranging from molecular dynamics to AI model training. Energy Secretary Chris Wright said the project will advance American leadership in science, AI, and high-performance computing. Nvidia CEO Jensen Huang called the project a time machine for science, enabling faster discovery across cancer treatments, quantum breakthroughs and foundational physics. The DOE said Doudna will support over 11,000 researchers and will bring together simulation, AI, and massive data sets on a single platform. Dell CEO Michael Dell (Trades, Portfolio) said the system would redefine the limits of high-performance computing and help address global scientific challenges. Investors may view the Doudna contract as a long-term catalyst for Nvidia and Dell, reinforcing their roles in national strategic infrastructure. Key upcoming events to watch include AI chip demand updates and the DOE's rollout timeline. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Cineverse's Dog Whisperer and Bob Ross FAST Channels Expand into Australia with Samsung TV Plus Australia Launch
LOS ANGELES, June 2, 2025 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, today announced the launch of its popular Dog Whisperer and Bob Ross channels on Samsung TV Plus Australia, marking the first time both channels have expanded into the country. Starting May 21, the channels will be available in the AU territory via Samsung's free, ad-supported streaming television (FAST) platform. Since Dog Whisperer debuted on Cineverse in January 2024, with all nine seasons and 160 episodes of Dog Whisperer with Cesar Millan, it has quickly become a top-performing channel for the Company. Cineverse holds the global rights to the famed pet dog series starring Cesar Millan, distributing it across multiple platforms, including launching the Dog Whisperer channel on Samsung TV Plus in the U.S. this past December. The Bob Ross Channel, a Cineverse partnership with Bob Ross Inc. and American Public Television since April 2020, quickly became one of the most popular FAST channels in the U.S. It is home to nearly 400 episodes of "The Joy of Painting," providing a nonstop feed of the iconic instructional painting show. Earlier this year, The Bob Ross Channel premiered the 13-episode series "The Joy of Painting with Nicholas Hankins: Bob Ross' Unfinished Season," in which certified Bob Ross instructor Nicholas Hankins completes Ross' final paintings, helping continue his legacy and inspire artists around the world. "Our Dog Whisperer and Bob Ross channels have captivated audiences around the globe with their timeless content and beloved characters," said Alexandra Viglione, Cineverse Vice President, Partnerships. "Given their strong track record of success, now is the perfect time to expand the reach of both channels and bring these hit shows to fans in Australia through our continuing partnership with Samsung TV Plus." "Even when Bob Ross was alive, Australians were really drawn to him and his painting technique," says Bob Ross Inc. president Joan Kowalski. "This is a wonderful move." About Cineverse StreamingCineverse owns and/or operates a wide range of premium streaming brands, from free, ad-supported streaming television (FAST) channels to subscription video-on-demand (SVOD) apps. These span fandoms – from single IP channels around pop cultural icons such as Bob Ross, The Dog Whisperer with Cesar Milan, Garfield and Barney, to channels curated for fans of Horror (Screambox, Midnight Pulp), Pan-Asian and Anime (RetroCrush, AsianCrush), Comedy (Comedy Dynamics), Documentary and Crime (Crime Hunters, Docurama), Independent Film (Fandor), Romance and Rom Coms (Dove Channel), to name a few. About CineverseCineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing non-rated film in U.S. history; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit About Samsung TV Plus Samsung TV Plus is a premium global entertainment service and is the most used streaming app on Samsung Smart TVs. As a leader in FAST, Samsung TV Plus offers hundreds of channels and thousands of shows and movies on-demand in the U.S. Globally, the streaming service carries over 3,500 ad-supported linear channels in 30 countries and is accessible on over 630M active devices. Samsung TV Plus is the exclusive home of Conan O'Brien TV, Letterman TV, and hundreds of additional exclusive channels available worldwide. Samsung TV Plus is available on Samsung TVs, Galaxy devices, Samsung Smart Monitor, and Family Hub. To learn more, visit Follow us on LinkedIn. CONTACTS For Media, The Lippin Group for Cineversecineverse@ For Investors, Julie Milsteadinvestorrelations@ View original content to download multimedia: SOURCE Cineverse Corp. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock
WASHINGTON, June 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes' or the 'Company'), today announced the pricing of an underwritten registered direct offering of 7,518,797 shares of its common stock at a price of $6.65 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50.0 million. The offering is expected to close on or about June 3, 2025, subject to the satisfaction of customary closing conditions. Cantor and Canaccord Genuity acted as joint book-running managers for the offering. The net proceeds of this offering are expected to be used for general corporate purposes, including working capital, operating expenses, and capital expenditures, as well as funding the disbursement to Renergen under our bridge loan agreement with Renergen. A shelf registration statement on Form S-3 (File No. 333-286860) relating to the offering of shares of common stock described above was declared effective by the Securities and Exchange Commission ('SEC') on May 30, 2025. The offering is being made only by means of a prospectus supplement and the accompanying prospectus that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's website at When available, copies of the final prospectus supplement and accompanying prospectus relating to these securities may also be obtained by sending a request to: Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at prospectus@ or Canaccord Genuity LLC, Attention: Syndication Department, 1 Post Office Square, 30th Floor, Boston, MA 02109, or by email at prospectus@ This press release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ('ASP technology'). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit Forward Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as 'believes,' 'plans,' 'anticipates,' 'expects,' 'estimates,' 'projects,' 'will,' 'may,' 'might,' and words of a similar nature. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including: the failure to obtain necessary regulatory and shareholder approvals for the proposed acquisition of Renergen; disruption from the proposed acquisition of Renergen making it more difficult to maintain business and operational relationships; significant transaction costs and unknown liabilities related to the proposed acquisition of Renergen; litigation or regulatory actions related to the proposed acquisition of Renergen; the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the proposed the construction and commissioning of our enrichment plant(s) or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions and contracts; dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; the competitive nature of our industry; and the factors disclosed in Part I, Item 1A. 'Risk Factors' of the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and any amendments thereto and in the company's subsequent reports and filings with the U.S. Securities and Exchange Commission. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad– Investor relationsEmail: Jassad@ 561-709-3043
